Nanobiocide Based-Silver Nanomaterials Upon Coronaviruses: Approaches for Preventing Viral Infections.
Kamyar KhoshnevisanHassan MalekiHadi BaharifarPublished in: Nanoscale research letters (2021)
The effectiveness of silver nanomaterials (AgNMs), as antiviral agents, has been confirmed in humans against many different types of viruses. Nanobiocides-based AgNMs can be effectively applied to eliminate coronaviruses (CoVs), as the cause of various diseases in animals and humans, particularly the fatal human respiratory infections. Mostly, these NMs act effectively against CoVs, thanks to the NMs' fundamental anti-viral structures like reactive oxygen species (ROS), and photo-dynamic and photo-thermal abilities. Particularly, the antiviral activity of AgNMs is clarified under three inhibitory mechanisms including viral entry limitation, attachment inhibition, and viral replication limitation. It is believed that nanobiocide with other possible materials such as TiO2, silica and, carbon NMs exclusively nano-graphene materials can emerge as a more effective disinfectant for long-term stability with low toxicity than common disinfectants. Nanobiocides also can be applied for the prevention and treatment of viral infections specifically against COVID-19.
Keyphrases
- sars cov
- reactive oxygen species
- respiratory syndrome coronavirus
- gold nanoparticles
- randomized controlled trial
- systematic review
- endothelial cells
- coronavirus disease
- oxidative stress
- dna damage
- cell death
- high resolution
- quantum dots
- mass spectrometry
- induced pluripotent stem cells
- smoking cessation
- carbon nanotubes
- combination therapy